Leading Edge Pharms announces MarketHub distribution deal
Leading Edge Pharms, a biotechnology company that develops cannabinoid therapies, as well as delivery systems, announced a new distribution deal with MarketHub.
The deal gives MarketHub the rights to distribute the Henderson, N.V.-based company’s line of Cannavera Pain Relief products with major retailers across the nation.
“MarketHub has set a high standard of quality for the hemp products we distribute to large retailers across the United States,” Shane Nance, the CEO of MarketHub said. “Leading Edge’s effective CBD-based pain relief solutions are exactly what trusted retailers would like to put on their shelves for consumers. We have seen the company’s commitment to quality in its approach to manufacturing and in its accurate labeling, which consumers can trust. We are aligned with Leading Edge in setting and delivering on this high standard for all CBD products.”
MarketHub’s distribution network includes more than 50,000 retail locations across the nation, as well as setting up “Hemp Health Zones” that direct shoppers to such products as CBD oils, the company said.
“It is important for us to make our pain relief products as accessible as possible,” CEO of Leading Edge Pharms, David Chadwick said. “The CBD industry is at an important point as many consumers are exploring the market and asking if CBD is the right solution for them. We are working hard to provide them with affordable, natural, safe and effective pain relief products. MarketHub’s large reach and market knowledge makes them a strong partner for us.”
Leading Edge’s portfolio includes CBD-based topical treatments that are developed with its proprietary compound, Silvidiol, which provides targeted pain relief and inflammation, the company said.
No comments found